NIPER Mohali Placements 2025: Highest & Average Package, Top Recruiters

National Institute of Pharmaceutical Education and Research’s 2025 placement season demonstrated robust performance with 213 postgraduate students placed out of 268 eligible, recording an impressive 79% placement rate as validated by the NIRF 2025 report. The institute attracted 40+ top-tier pharmaceutical and biotechnology recruiters, resulting in 250+ total offers, marking a 12% growth from 2024 and highlighting NIPER’s strong industry connect. The highest salary package touched ₹15 LPA, offered by Pfizer to MPharm graduates, while the average package ranged ₹6–8 LPA, and the median CTC stood at ₹6.05 LPA for two-year PG programs.

Across specializations, MPharm dominated placements with 120 selections, driven by demand in pharmaceutics, regulatory toxicology, and analytical streams. MS (Pharm) saw strong uptake in Biotechnology and Pharmacoinformatics roles, while MBA (Pharm) students secured managerial positions at Novartis with packages up to ₹10 LPA. MTech graduates were placed in formulation and process development profiles at firms like Himalaya and Biocon. Core recruiters—Pfizer, Novartis, Zydus Cadila, Dr. Reddy’s, Syngene, Biocon, Lupin, and Himalaya—together hired the majority of candidates, reflecting industry confidence in NIPER-trained talent.

National Institute of Pharmaceutical Education and Research Placement Cell strengthened outcomes through 30+ employability workshops, technical masterclasses, mock interviews, and 150+ internship opportunities in premier labs, targeting a future placement benchmark of 90%. With strong R&D hiring trends and expanding domestic pharma hubs, NIPER Mohali continues to position its students for high-impact careers, making these insights vital for NIPER JEE 2026 aspirants evaluating postgraduate prospects.

NIPER Mohali’s 2025 placement cycle recorded strong performance with 250+ total offers and 40+ recruiting companies, marking a 12% growth from the previous year. With a 79% placement rate (213/268 PG students) as per NIRF data, most roles were driven by India’s expanding drug discovery and R&D ecosystem, supported by robust summer internship pipelines.

National Institute of Pharmaceutical Education and Research’s 2025 recruitment showcased strong demand across R&D, regulatory, biotech, and analytical domains, with top companies like Pfizer, Novartis, and Dr. Reddy’s offering diverse, high-value roles. Hiring spanned core specializations such as pharmaceutics, biotechnology, toxicology, and regulatory affairs, reinforcing the institute’s industry-aligned training and placement strength.

For More Information, Visit NIPER Mohali.

NIPER Mohali’s 2025 placement package trends remained stable, with the average salary ranging between ₹6–8 LPA for 213 placed PG students and the highest package touching ₹15 LPA at Pfizer. With 70% of offers clustering in the ₹5.5–7 LPA range, NIRF’s ₹6.05 LPA median further supports consistent outcomes for 2026 aspirants.

NIPER Mohali's branch-wise placements in 2025 favored MPharm with 120 students placed, 56% of PG offers on formulation demand—answering "NIPER Mohali MPharm placements 2025" with Rs. 7 Lakhs averages from Dr. Reddy's. MS (Pharm) followed at 45 placed, MBA (Pharm) 30 in management.

NIPER Mohali has recorded steady improvement in placements, rising from 185 placed students in 2023 to 213 in 2025, with the median CTC increasing from ₹5.5 LPA to ₹6.05 LPA. Recruiter participation also grew, resulting in 250+ offers in 2025.

NIPER Mohali's Placement Cell coordinated 30+ workshops in 2025 on resume building and interviews, aiming 90% rates via pharma MOUs—answering "NIPER Mohali placement process." Team tracks 500 profiles for drives.

• Aptitude Training: 15 sessions with Zydus
• Soft Skills: 10 mocks with Novartis
• Industry Visits: 5 trips to Dr. Reddy's labs
• Internship Aid: 150 summer spots at Pfizer